Chugai Pharmaceutical Co 4519.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4519.T. It has been listed since 3 March 1956. In the fiscal year to 31 December 2025, it reported revenue of ¥1.26trn and net income of ¥434.01bn. At that date it held total assets of ¥2.47trn and shareholders' equity of ¥2.03trn.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The firm is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The firm operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Osamu OkudaPresident, Chief Executive Officer, Representative Director, since 2014¥375.0m
• Mr. Iwaaki TaniguchiSenior Executive Officer, Chief Financial Officer, Senior Manager of Finance, Director, since 2022
• Dr. Hitoshi IikuraSenior Executive Officer, Chief Director of Translational Research, Director, since 2022
• Mr. Junichi EbiharaSenior Executive Officer
• Mr. Shinji HidakaSenior Executive Officer
• Mr. Tsukasa KusanoSenior Executive Officer, Manager of Project Life Cycle Management Unit
• Mr. Norihisa OnozawaSenior Executive Officer, Director of Corporate Planning
• Dr. Kaori OuchiSenior Executive Officer
• Mr. Tetsuya YamaguchiSenior Executive Officer, Manager of PHC Solution Unit
• Mr. Yoshiyuki YanoSenior Executive Officer
• Mr. Naoya FujiharaExecutive Officer
• Mr. Masayoshi HiguchiExecutive Officer, Director of Reliability Assurance Planning, Manager of Reliability Assurance Unit

Overall

93

Environment

99

Social

99

Governance

80

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.